ORBIMED ADVISORS LLC 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:10 pm Sale |
2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
ORBIMED ADVISORS LLC | 0 0.000% |
-484,525 (Position Closed) |
Filing |
| 2021-02-12 4:37 pm Purchase |
2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
ORBIMED ADVISORS LLC | 484,525 4.970% |
90,116 (+22.85%) |
Filing |